Therapy of Graves’ disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism

[1]  A. Berghout,et al.  Sodium ipodate in the preparation of Graves' hyperthyroid patients for thyroidectomy. , 1989, Hormone research.

[2]  A. Pinchera,et al.  Effect of amiodarone on circulating antithyroid antibodies. , 1988, British medical journal.

[3]  D. L. Germain,et al.  Dual mechanisms of regulation of type I iodothyronine 5'-deiodinase in the rat kidney, liver, and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents. , 1988 .

[4]  L. Braverman,et al.  COMPARISON OF METHIMAZOLE, METHIMAZOLE AND SODIUM IPODATE, AND METHIMAZOLE AND SATURATED SOLUTION OF POTASSIUM IODIDE IN THE EARLY TREATMENT OF HYPERTHYROID GRAVES’DISEASE , 1988, Clinical endocrinology.

[5]  J. Hershman,et al.  Long term treatment of Graves' disease with iopanoic acid (Telepaque). , 1987, The Journal of clinical endocrinology and metabolism.

[6]  A. Pinchera,et al.  Amiodarone: a common source of iodine-induced thyrotoxicosis. , 1987, Hormone research.

[7]  H. Suzuki,et al.  PROLONGED TREATMENT OF HYPERTHYROIDISM WITH SODIUM TYROPANOATE, AN ORAL CHOLECYSTOGRAPHIC AGENT: A RE‐EVALUATION OF ITS CLINICAL UTILITY , 1986, Clinical endocrinology.

[8]  E. Roti,et al.  Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves’ disease , 1986, Journal of endocrinological investigation.

[9]  A. Pinchera,et al.  IS HUMORAL THYROID AUTOIMMUNITY RELEVANT IN AMIODARONE IODINE‐INDUCED THYROTOXICOSTS (AIIT)? , 1986, Clinical endocrinology.

[10]  A. Pinchera,et al.  Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole , 1986, Journal of endocrinological investigation.

[11]  M. L. Santos,et al.  Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. , 1986, British medical journal.

[12]  M. Dufau,et al.  DEFINITION OF BIOACTIVE PROLACTIN PULSATIONS DURING THE MENSTRUAL CYCLE , 1986, Clinical endocrinology.

[13]  D. Solomon,et al.  Long term treatment of Graves' hyperthyroidism with sodium ipodate. , 1985, The Journal of clinical endocrinology and metabolism.

[14]  P. Laurberg.  Multisite inhibition by ipodate of iodothyronine secretion from perfused dog thyroid lobes. , 1985, Endocrinology.

[15]  L. Braverman,et al.  COMPARATIVE EFFECTS OF SODIUM IPODATE AND IODIDE ON SERUM THYROID HORMONE CONCENTRATIONS IN PATIENTS WITH GRAVES' DISEASE , 1985, Clinical endocrinology.

[16]  D. Solomon,et al.  Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism. , 1982, The Journal of clinical endocrinology and metabolism.

[17]  J. Hershman,et al.  Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol. , 1981, The Journal of clinical endocrinology and metabolism.

[18]  W. Nelp,et al.  Inhibition of hepatic binding of thyroxine by cholecystographic agents. , 1980, The Journal of clinical investigation.

[19]  P. Romelli,et al.  Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay , 1979, Journal of endocrinological investigation.

[20]  D. Solomon,et al.  The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism. , 1978, The Journal of clinical endocrinology and metabolism.

[21]  D. Solomon,et al.  Pathways of metabolism of thyroid hormones. , 1978, Recent progress in hormone research.